Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-25-002910
Filing Date
2025-03-18
Accepted
2025-03-18 09:06:14
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 cvm_424b5.htm 424B5 436564
2 cvm_424b5img8.jpg GRAPHIC 30894
3 cvm_424b5img24.jpg GRAPHIC 6761
4 cvm_424b5img23.jpg GRAPHIC 36452
5 cvm_424b5img20.jpg GRAPHIC 32022
6 cvm_424b5img19.jpg GRAPHIC 40456
7 cvm_424b5img17.jpg GRAPHIC 32126
8 cvm_424b5img15.jpg GRAPHIC 19992
9 cvm_424b5img13.jpg GRAPHIC 22116
10 cvm_424b5img12.jpg GRAPHIC 22094
11 cvm_424b5img11.jpg GRAPHIC 4583
  Complete submission text file 0001654954-25-002910.txt   779753
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-265995 | Film No.: 25746625
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)